Redefining the early detection and clinical management of cancer.

BD Diagnostics - TriPath:
Women’s health is our primary focus.

BD Diagnostics - TriPath has developed and continues to develop solutions that:

  • Identify women with cancer at the earliest possible stage of the disease.
  • Provide women and their physicians with individualized predictive and prognostic information about disease state and outcome.
  • Help guide the treatment selection based on advanced diagnostic techniques.
  • Help predict disease recurrence.

We are committed to providing you with the best diagnostic tools for caring for your patients.
BD Diagnostics
- TriPath provides a solution for everyone.

For patients
For clinicians
For the lab
For patients
For clinicians
For the lab
She wants to feel secure in knowing she is getting the best Pap test possible. For her, that means avoiding unnecessary repeat tests due to an 'unsatisfactory' case and feeling confident with the result.
Clinicians don't want to worry about her Pap test results. They want a Pap test that provides safe, effective, and reliable results. That means reducing patient call backs and ensuring 100% of the collected sample is sent to the lab for processing.
Laboratories want a Pap test that has high accuracy and reproducibility. The automated processing and screening of
BD SurePath™ slides provides increased throughput and workflow efficiencies.

BD SurePath™ Pap test unique collection and processing is changing cervical cancer screening for the better.
BD SurePath™ liquid-based Pap test

Learn more about and try our BD SurePath™ liquid-based Pap test.

Learn more about our new Molecular Oncology products and programs for detection and prognosis of breast, ovarian, cervical, and other cancers.

Information about cancer, diagnosis, and links to other professional sites, click here.

Learn more about BD Diagnostics - TriPath.